Satya Das

5.6k citations

55 papers · 1.6k · 2 hit papers · h-index 16

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Epidemiology top 5%
- Neuroendocrine Tumor Research Advances

Papers in

Oncology 37
- Lung Cancer Research Studies 17
- Cancer Immunotherapy and Biomarkers 13
- Colorectal Cancer Treatments and Studies 9
- Pancreatic and Hepatic Oncology Research 5
Epidemiology 22
- Neuroendocrine Tumor Research Advances 22

Co-authors: Douglas B. Johnson (2 shared papers)Arvind Dasari (4 shared papers)Jordan Berlin (28 shared papers)Jonathan Strosberg (5 shared papers)Taymeyah Al‐Toubah (3 shared papers)Ghassan El‐Haddad (2 shared papers)Sigurdís Haraldsdóttir (5 shared papers)Dana B. Cardin (12 shared papers)
Journals: Journal of Clinical Oncology (10 papers)The Oncologist (4 papers)JAMA Oncology (3 papers)Current Treatment Options in Oncology (3 papers)Cancers (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Satya Das

51 papers receiving 1.6k citations

Satya Das's Hit Papers

align trajectories log scale

Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? 2021 · 218 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Current Oncology Reports
2019 Journal for ImmunoTherapy of Cancer

Peers

Countries citing papers authored by Satya Das

Since Specialization

Citations

This map shows the geographic impact of Satya Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satya Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satya Das more than expected).

Fields of papers citing papers by Satya Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satya Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satya Das. The network helps show where Satya Das may publish in the future.

Co-authors

The 25 scholars most cited alongside Satya Das, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satya Das Line = papers co-authored together Satya Das links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors Journal for ImmunoTherapy of Cancer ·Satya Das, Douglas B. Johnson Hit paper breakdown →	2019	806
2	Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Current Oncology Reports ·Satya Das, Arvind Dasari Hit paper breakdown →	2021	218
3	¹⁷⁷Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors Expert Review of Gastroenterology & Hepatology ·Satya Das, Taymeyah Al‐Toubah, Ghassan El‐Haddad, Jonathan Strosberg	2019	93
4	Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti–PD-1/PD-L1 therapy Human Pathology ·Jordan Roberts, Raul S. González, Satya Das, Jordan Berlin, Chanjuan Shi	2017	44
5	Promising New Agents for Colorectal Cancer Current Treatment Options in Oncology ·Satya Das, Kristen K. Ciombor, Sigurdís Haraldsdóttir, Richard M. Goldberg	2018	42
6	Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy The Oncologist ·Satya Das, Kristen K. Ciombor, Sigurdís Haraldsdóttir, Yoanna S Pumpalova, İbrahim Halil Şahin, Gino Pineda, Yu Shyr, Emily Pei-Ying Lin, Chih–Yuan Hsu, Shih‐Kai Chu, Laura W. Goff, Dana B. Cardin, Mehmet Asım Bilen, George A. Fisher, Christina Wu, Jordan Berlin	2020	38
7	Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer The Oncologist ·İbrahim Halil Şahin, Subir Goyal, Yoanna S Pumpalova, Mohamad Bassam Sonbol, Satya Das, Sigurdís Haraldsdóttir, Daniel H. Ahn, Kristen K. Ciombor, Zhengjia Chen, Amber Draper, Jordan Berlin, Tanios Bekaii‐Saab, Gregory B. Lesinski, Bassel F. El‐Rayes, Christina Wu	2021	35
8	Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors Therapeutic Advances in Medical Oncology ·Satya Das, Arvind Dasari	2021	23
9	Improving the phenotype risk score as a scalable approach to identifying patients with Mendelian disease Journal of the American Medical Informatics Association ·Lisa Bastarache, Jacob Hughey, (unknown), Julie A Bastraache, Satya Das, Neil Charles Zaki, Chenjie Zeng, Leigh Anne Tang, Dan M. Roden, Joshua C. Denny	2019	22
10	Chemotherapy in Neuroendocrine Tumors Cancers ·Satya Das, Taymeyah Al‐Toubah, Jonathan Strosberg	2021	22
11	First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-¹¹C]-Glutamine in Patients with Metastatic Colorectal Cancer Journal of Nuclear Medicine ·Allison S. Cohen, Joe Grudzinski, Gary T. Smith, Todd E. Peterson, Jennifer G. Whisenant, Tiffany L. Hickman, Kristen K. Ciombor, Dana B. Cardin, Cathy Eng, Laura W. Goff, Satya Das, Robert J. Coffey, Jordan Berlin, H. Charles Manning	2021	21
12	The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience Cancer Imaging ·Satya Das, Gino Pineda, Laura W. Goff, Rachel K. Sobel, Jordan Berlin, George A. Fisher	2018	20
13	Immunotherapy After Immunotherapy: Response Rescue in a Patient With Microsatellite Instability-high Colorectal Cancer Post-Pembrolizumab Clinical Colorectal Cancer ·Satya Das, Audrey Allen, Jordan Berlin	2020	19
14	Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy Expert Review of Anticancer Therapy ·Marc Roth, Satya Das	2020	19
15	Combining anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) and -programmed cell death protein 1 (PD-1) agents for cancer immunotherapy Expert Opinion on Biological Therapy ·Selina K. Wong, Kathryn E. Beckermann, Douglas B. Johnson, Satya Das	2021	19
16	Harnessing the Immune System in Pancreatic Cancer Current Treatment Options in Oncology ·Satya Das, Jordan Berlin, Dana B. Cardin	2018	17
17	Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor The American Journal of Surgical Pathology ·Martha Frances Wright, Justin Cates, Raul S. González, Satya Das, Jordan Berlin, Chanjuan Shi	2019	14
18	External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy JAMA Network Open ·Satya Das, Aman Chauhan, Liping Du, Katharine Thomas, Aasems Jacob, Aimee Schad, Shikha Jain, Aaron Jessop, Chirayu Shah, David Eisner, Dana B. Cardin, Kristen K. Ciombor, Laura W. Goff, Marques L. Bradshaw, Dominique Delbeke, Martin P. Sandler, Robert A. Ramirez, Jordan Berlin	2022	14
19	Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy. Journal of Clinical Oncology ·Satya Das, Kristen K. Ciombor, Sigurdís Haraldsdóttir, Yoanna S Pumpalova, İbrahim Halil Şahin, Yu Shyr, Shih‐Kai Chu, Emily Pei-Ying Lin, Chih–Yuan Hsu, Laura W. Goff, Dana B. Cardin, Mehmet Asım Bilen, Jordan Berlin, Christina Wu	2019	12
20	Somatostatin receptor radionuclide therapy in neuroendocrine tumors Endocrine Related Cancer ·Mintallah Haider, Satya Das, Taymeyah Al‐Toubah, Eleonora Pellè, Ghassan El‐Haddad, Jonathan Strosberg	2021	11

About Satya Das

Satya Das is a scholar working on Oncology, Epidemiology, Neurology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (22 papers), Lung Cancer Research Studies (17 papers), Neuroblastoma Research and Treatments (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Oncology (1.0k citations), Epidemiology (449 citations), Neurology (200 citations), Immunology (202 citations) and Pulmonary and Respiratory Medicine (180 citations). Satya Das has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Douglas B. Johnson, Arvind Dasari, Jordan Berlin, Jonathan Strosberg, Taymeyah Al‐Toubah, Ghassan El‐Haddad, Sigurdís Haraldsdóttir, Dana B. Cardin, Kristen K. Ciombor and Chanjuan Shi. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, JAMA Oncology, Current Treatment Options in Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Satya Das

Impact in

Papers in i

In The Last Decade

Satya Das

Satya Das's Hit Papers

Peers

Countries citing papers authored by Satya Das

Fields of papers citing papers by Satya Das

All Works

About Satya Das

Explore authors with similar magnitude of impact

Papers in